Stemgent Finds $5.6M More
Summary
Stemgent Finds $5.6M More Xconomy Boston — Stemgent, a provider of consumable research materials for stem cell scientists, has raised $5.6 million of a planned $10.1 million round of equity funding, according to an SEC filing.The funding includes the conversion of promissory notes.The company, which has offices in Cambridge, MA, and San Diego, previously raised $14 million in March 2009 from HealthCare Ventures and Morgenthaler Ventures.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected